Xylem Inc. (NYSE:XYL) Stock Rated "Moderate Buy" by Wall Street Analysts

Key Points

• Analyst sentiment is moderately bullish: Nine of 16 covering brokerages rate Xylem a buy, while seven recommend holding the stock. The average 12-month price target is $155.
• Xylem reported quarterly EPS of $1.46, exceeding the $1.34 consensus estimate, while revenue reached $2.34 billion and grew 1.5% year over year. The company issued fiscal 2026 EPS guidance of $5.55–$5.70.
• The company declared a quarterly dividend of $0.43 per share, equivalent to $1.72 annually and a 1.7% yield. Institutional investors own approximately 88% of Xylem’s outstanding shares.

Shares of Xylem Inc. (NYSE:XYL - Get Free Report) have been given an average rating of "Moderate Buy" by the sixteen brokerages that are presently covering the company, Marketbeat reports. Seven analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $155.00.

XYL has been the subject of a number of recent analyst reports. Royal Bank Of Canada boosted their price objective on Xylem from $159.00 to $164.00 and gave the company an "outperform" rating in a report on Wednesday, July 29th. Barclays lifted their target price on Xylem from $154.00 to $159.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 29th. Weiss Ratings reissued a "hold (c)" rating on shares of Xylem in a research note on Wednesday, August 5th. Stifel Nicolaus upped their price target on shares of Xylem from $157.00 to $160.00 and gave the stock a "buy" rating in a report on Wednesday, July 29th. Finally, Citigroup reaffirmed a "buy" rating on shares of Xylem in a research note on Wednesday, July 29th.

Xylem Price Performance

XYL stock opened at $101.30 on Thursday. Xylem has a 12 month low of $100.17 and a 12 month high of $154.27. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23. The company has a 50-day moving average price of $112.62 and a 200 day moving average price of $115.34. The stock has a market cap of $23.65 billion, a PE ratio of 24.12, a P/E/G ratio of 1.62 and a beta of 1.00.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, topping analysts' consensus estimates of $1.34 by $0.12. The company had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The firm's revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Equities research analysts anticipate that Xylem will post 5.66 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Thursday, August 27th. Xylem's dividend payout ratio is currently 40.95%.

Institutional Trading of Xylem

Several institutional investors and hedge funds have recently modified their holdings of XYL. Commonwealth Retirement Investments LLC purchased a new stake in shares of Xylem in the 4th quarter worth $27,000. Dunhill Financial LLC bought a new stake in shares of Xylem in the second quarter valued at about $30,000. Avalon Trust Co purchased a new stake in Xylem in the second quarter worth about $35,000. Orion Capital Management LLC purchased a new stake in Xylem in the second quarter worth about $35,000. Finally, Aventus Investment Advisors Inc. grew its holdings in Xylem by 66.7% during the 2nd quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company's stock worth $35,000 after acquiring an additional 120 shares in the last quarter. Institutional investors own 87.96% of the company's stock.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that develops products, services and solutions for the movement, treatment, testing and efficient use of water. Its offerings serve municipal water and wastewater systems, utilities, industrial customers, commercial buildings and other infrastructure operators.

The company's portfolio includes water and wastewater pumps, mixing and aeration equipment, treatment systems, measurement and monitoring technologies, smart metering, network-management software, and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.